Dr. Michael Cross PhD, MBA, is the Chief Operating Officer of ARTMS and has responsibilities that include business and corporate development, strategy and operations. Dr. Cross is also responsible for all commercialization activities at the Centre for Probe Development and Commercialization in Hamilton, ON. Michael has over 20 years of industry experience with a successful background in venture capital financing, operations and business development transactions. Michael was the co-founder/COO/CBO of OncoSec Medical, an immuno-oncology company in San Diego. Before starting OncoSec Michael was the SVP and co-lead of a $330M Canadian life sciences venture fund. Michael has held senior positions at Viventia Biotech, MDS Proteomics, MDS Capital and the Toronto Raptors basketball team. Michael received his PhD in physiology from the University of Toronto and completed his post-doctoral training with the Department of Defence.